Platelet factor 4 (PF‐4) blocks the binding of basic fibroblast growth factor (bFGF) to its receptor. In the present study, we constructed carboxyl‐terminal fragments, which represent the heparin‐binding region of the PF‐4 molecule, and examined whether these synthetic peptides retain the blocking effects on the receptor binding of bFGF. Synthetic peptides inhibited the receptor binding of bFGF. Furthermore, they inhibited the migration and tube formation of bovine capillary endothelial cells in culture (these phenomena are dependent on endogenous bFGF).
|Number of pages||4|
|Journal||Japanese Journal of Cancer Research|
|Publication status||Published - 1993 May|
- Basic fibroblast growth factor
- Heparin‐binding domain
- Platelet factor 4
- Receptor binding